Clinical trial
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
NCT00027443 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00027443 |
|---|---|
| Title | Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis |
| Official title | Giant Cell Myocarditis Treatment Trial Pilot Study |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Myocarditis |
| Intervention type | Drug |
| Interventions | Muromonab-CD3, Cyclosporine |
| Enrollment | 40 |
| Start date | Aug 1, 2001 |
| Completion | Jul 1, 2007 |
| First posted | Dec 7, 2001 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: